Wangxi Luo is a skilled scientist with expertise in biomarker immunoassays development and validation, currently employed at Moderna since February 2024. Prior to this role, Wangxi served as a Senior Scientist at Frontage Laboratories, Inc., where involvement in the biomarker team focused on developing detection methods for pharmaceutical companies from December 2021 to March 2024. Wangxi gained substantial research experience as a Postdoctoral Researcher at the University of Pennsylvania and at Temple University, contributing to cell imaging studies from January 2014 to January 2022. Earlier in the career, Wangxi worked as a Practice Consultant at Accenture, designing pricing evaluation models for steel products in late 2013. Educational qualifications include a Bachelor's degree in Chemical Biology from Tsinghua University and a Ph.D. from the Institute of Chemistry, Chinese Academy of Sciences.
This person is not in any teams
This person is not in any offices